Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "disease"

3223 News Found

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
Hospitals | November 05, 2021

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease

The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day


Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age


CDSCO approves Exablate 4000 for patients living with Parkinson’s disease
Medical Device | September 20, 2021

CDSCO approves Exablate 4000 for patients living with Parkinson’s disease

The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain


Machine Learning to understand and prevent disease
Digitisation | September 17, 2021

Machine Learning to understand and prevent disease

Barbara Engelhardt moves her computational and statistics lab to Gladstone


Covid-19 vaccine clinical trial for people with autoimmune disease
Drug Approval | September 03, 2021

Covid-19 vaccine clinical trial for people with autoimmune disease

Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study


Japan approves AstraZeneca’s Forxiga for chronic kidney disease
Drug Approval | August 28, 2021

Japan approves AstraZeneca’s Forxiga for chronic kidney disease

Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options


FDA approves Nexviazyme for late-onset Pompe disease
Drug Approval | August 09, 2021

FDA approves Nexviazyme for late-onset Pompe disease

Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells


Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
News | June 25, 2026

Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal

Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


CARE Hospitals completes 500 robotic knee replacement surgeries in one year
Hospitals | June 24, 2026

CARE Hospitals completes 500 robotic knee replacement surgeries in one year

Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.